Ginkgo Bioworks Holdings, Inc. Profile Avatar - Palmy Investing

Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived…

Biotechnology
US, Boston [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of DNA's Analysis
CIK: - CUSIP: 37611X100 ISIN: US37611X1000 LEI: - UEI: -
Secondary Listings
DNA has no secondary listings inside our databases.